Disease management

The cancer-care company will expand its reach within the healthcare system to provide more oncology patients access to its remote coordinated-care services.

The partnership aims to raise patient safety, boost cost-effectiveness and improve care by combining Glytec's software with Roche's system.

The partnership aims to combine Imidex's chest X-ray technology with Orbit's DNA sequencing technology to advance the early detection of lung cancer.

The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.

Also, a Korean clinical data solutions provider has utilised Amazon's genAI to automate medical coding.

The hydrogel-based sensor can continuously monitor cholesterol and lactate on the skin. 

Also, PenCS has launched a new stroke functionality.

It is also solidifying its presence in the United States market through Cedars-Sinai's backing.

The t:slim X2 Pump is compatible with Dexcom G7 and G6 continuous glucose monitoring systems and was cleared for sale by Health Canada.

DarioHealth's chief medical officer, Dr. Omar Manejwala, talks about how the company helps employers support employees with chronic conditions, the advancement of its platform after its Twill acquisition, and expanding its reach with Medicaid.